Fundraising Fox

Enumera Molecular

Ann Arbor, US · Founded 2022 · Delaware corporation · 1 known investors

enumeramolecular.com

Enumera Molecular develops the EnumeraPlex platform, a molecular diagnostics system offering a range of tests with a single workflow and clear result readouts for clinical laboratories. It targets application areas including oncology, reproductive health, transplant, pharmacogenomics, and infectious disease testing.

BiotechHealthtechMedical Devicesin /enumera-molecular

Founders & leadership

MC
Matthew CooperCEO & Co-founder
DK
Dan KidleDirector
EH
Elaine HeronDirector
SB
Sundaresh BrahmasandraDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$12.3MraisedJul 2026 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew CooperExecutive Officer, Director
  • Dan KidleDirector
  • Elaine HeronDirector
  • Sundaresh BrahmasandraDirector
Offering amount
$17.4M
Amount sold
$12.3M
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$18.7MraisedAug 2022 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew CooperExecutive Officer, Director
Offering amount
$19M
Amount sold
$18.7M
First sale
May 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.